A novel intronic polymorphism of ABCA1 gene reveals risk for sporadic Alzheimer's disease in Chinese

American Journal of Medical Genetics, Part B: Neuropsychiatric Genetics

Volumn 144, Issue 8, 2007, Pages 1007-1013

  Leung, Wing Chu ^a   Li, Yan ^a   Li, Zhong ^a,b   Tang, Alan Y B ^a   Cheung, Bernard M Y ^a   Leung, Raymond Y H ^a   Yik, Ping Yiu ^a   Jin, Dong Yan ^a   Song, You Qiang ^a  

^a UNIVERSITY OF HONG KONG   (Hong Kong)

^b SUN YAT SEN UNIVERSITY   (China)

Author keywords

ABCA1; Alzheimer's disease; Association; Case control; Haplotype; Single nucleotide polymorphisms (SNP)

Indexed keywords

ABC TRANSPORTER A1;

AGED; ALZHEIMER DISEASE; AMINO ACID SUBSTITUTION; ARTICLE; CASE CONTROL STUDY; CHINESE; CONTROLLED STUDY; FEMALE; GENE LINKAGE DISEQUILIBRIUM; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENETIC RISK; HAPLOTYPE; HUMAN; HUMAN TISSUE; INTRON; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN STRUCTURE; SINGLE NUCLEOTIDE POLYMORPHISM;

AGE OF ONSET; AGED; AGED, 80 AND OVER; ALZHEIMER DISEASE; ASIAN CONTINENTAL ANCESTRY GROUP; ATP-BINDING CASSETTE TRANSPORTERS; CASE-CONTROL STUDIES; CHINA; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HAPLOTYPES; HUMANS; INTRONS; LINKAGE DISEQUILIBRIUM; MALE; POLYMORPHISM, SINGLE NUCLEOTIDE; QUANTITATIVE TRAIT, HERITABLE;

EID: 36749014486     PISSN: 15524841     EISSN: 1552485X     Source Type: Journal    
DOI: 10.1002/ajmg.b.30525     Document Type: Article

References (30)

1. Abildayeva K, Jansen PJ, Hirsch-Reinshagen V, Bloks VW, Bakker AH, Ramaekers FC, de Vente J, Groen AK, Wellington CL, Kuipers F, Mulder M. 2006. 24(S)-hydroxycholesterol participates in a liver X receptor-controlled pathway in astrocytes that regulates apolipoprotein E-mediated cholesterol efflux. J Biol Chem 281:12799-12808.
2. Barrett JC, Fry B, Maller J, Daly MJ. 2005. Haploview: Analysis and visualization of LD and haplotype maps. Bioinformatics 21:263-265.
3. Bodzioch M, Orso E, Klucken J, Langmann T, Bottcher A, Diederich W, Drobnik W, Barlage S, Buchler C, Porsch-Ozcurumez M, Kaminski WE, Hahmann HW, Oette K, Rothe G, Aslanidis C, Lackner KJ, Schmitz G. 1999. The gene encoding ATP-binding cassette transporter 1 is mutated in tangier disease. Nat Genet 22:347-351.
4. Brooks-Wilson A, Marcil M, Clee SM, Zhang LH, Roomp K, van Dam M, Yu L, Brewer C, Collins JA, Molhuizen HO, Loubser O, Ouelette BF, Fichter K, Ashbourne-Excoffon KJ, Sensen CW, Scherer S, Mott S, Denis M, Martindale D, Frohlich J, Morgan K, Koop B, Pimstone S, Kastelein JJ, Genest J Jr, Hayden MR. 1999. Mutations in ABC1 in tangier disease and familial high-density lipoprotein deficiency. Nat Genet 22:336-345.
5. Chiu KC, Chu LW, Chung CP, Hu W, Chan F, Pei C, Hui SL. 2002. Clinical features of Alzheimer's disease in a regional Memory Clinic in Hong Kong. J Hong Kong Geriatr Soc 11:21-27.
6. Chu LW, Ma ES, Lam KK, Chan MF, Lee DH. 2005. Increased alpha 7 nicotinic acetylcholine receptor protein levels in Alzheimer's disease patients. Dement Geriatr Cogn Disord 19:106-112.
7. Efron B, Tibshirani RJ. 1993. An introduction to the bootstrap. London: Chapman & Hall
8. Fitzgerald ML, Morris AL, Rhee JS, Andersson LP, Mendez AJ, Freeman MW. 2002. Naturally occurring mutations in the largest extracellular loops of ABCA1 can disrupt its direct interaction with apolipoprotein A-I. J Biol Chem 277:33178-33187.
9. Frikke-Schmidt R, Nordestgaard BG, Jensen GB, Tybjaerg-Hansen A. 2004. Genetic variation in ABC transporter A1 contributes to HDL cholesterol in the general population. J Clin Invest 114:1343-1353.
10. Hirsch-Reinshagen V, Maia LF, Burgess BL, Blain JF, Naus KE, McIsaac SA, Parkinson PF, Chan JY, Tansley GH, Hayden MR, Poirier J, Van Nostrand W, Wellington CL. 2005. The absence of ABCA1 decreases soluble ApoE levels but does not diminish amyloid deposition in two murine models of Alzheimer disease. J Biol Chem 280:43243-43256.
11. Jick H, Zornberg GL, Jick SS, Seshadri S, Drachmen DA. 2000. Statins and the risk of dementia. Lancet 356:1627-1631.
12. Katzov H, Chalmers K, Palmgren J, Andreasen N, Johansson B, Cairns NJ, Gatz M, Wilcock GK, Love S, Pedersen NL, Brookes AJ, Blennow K, Kehoe PG, Prince JA. 2004. Genetic variants of ABCA1 modify Alzheimer disease risk and quantitative traits related to beta-amyloid metabolism. Hum Mutat 23:358-367.
13. Kivipelto M, Helkala EL, Laakso MP, Hanninen T, Hallikainen M, Alhainen K, Soininen H, Tuomilehto J, Nissinen A. 2001. Midlife vascular risk factors and Alzheimer's disease in later life: Longitudinal, population based study. BMJ 322:1447-1451.
14. Koldamova R, Staufenbiel M, Lefterov I. 2005. Lack of ABCA1 considerably decreases brain ApoE level and increases amyloid deposition in APP23 mice. J Biol Chem 280:43224-43235.
15. Li Y, Tacey K, Doil L, van Luchene R, Garcia V, Rowland C, Schrodi S, Leong D, Lau K, Catanese J, Sninsky J, Nowotny P, Holmans P, Hardy J, Powell J, Lovestone S, Thal L, Owen M, Williams J, Goate A, Grupe A. 2004. Association of ABCA1 with late-onset Alzheimer's disease is not observed in a case-control study. Neurosci Lett 366:268-271.
16. Li Y, Leung WC, Chen YQ, Cheung BMY, Liang RYH, Yik PY, Ng KM, Mak W, Jin DY, st. George-Hyslop P, Song YQ. 2006. Intron 2 (T/C) CYP46 polymorphism is associated with Alzheimer's disease in Chinese. Dement Geriatr Cogn Disord 22:399-404.
17. McKhann G, Drachman D, Folstein M, Katzman R, Price D, Stadlan EM. 1984. Clinical diagnosis of Alzheimer's disease: Report of the NINCDS-ADRDA work group under the auspices of department of health and human services task force on Alzheimer's disease. Neurology 34:939-944.
18. Neale BM, Sham PC. 2004. The future of association studies: Gene-based analysis and replication. Am J Hum Genet 75:353-362.
19. Ott J. 1988. Utility Programs for Analysis of Genetic Linkage, Program HWE. URL http://www.hgmp.mrc.ac.uk/Registered/Help/linkutil/.
20. Schmitz G, Kaminski WE, Orso E. 2000. ABC transporters in cellular lipid trafficking. Curr Opin Lipidol 11:493-501.
21. Shibata N, Kawarai T, Lee JH, Lee HS, Shibata E, Sato C, Liang Y, Duara R, Mayeux RP, St George-Hyslop PH, Rogaeva E. 2006. Association studies of cholesterol metabolism genes (CH25H, ABCA1 and CH24H) in Alzheimer's disease. Neurosci Lett 391:142-146.
22. Simons M, Keller P, Dichgans J, Schulz JB. 2001. Cholesterol and Alzheimer's disease: Is there a link? Neurology 57:1089-1093.
23. Song YQ, Rogaeva E, Premkumar S, Brindle N, Kawarai T, Orlacchio A, Yu G, Levesque G, Nishimura M, Ikeda M, Pei Y, O'Toole C, Duara R, Barker W, Sorbi S, Freedman M, Farrer L, St George-Hyslop P. 1998. Absence of association between Alzheimer disease and the -491 regulatory region polymorphism of ApoE. Neurosci Lett 250:189-192.
24. Ramensky V, Bork P, Sunyaev S. 2002. Human non-synonymous SNPs: Server and survey. Nucleic Acids Res 30:3894-3900.
25. Wahrle SE, Jiang H, Parsadanian M, Hartman RE, Bales KR, Paul SM, Holtzman DM. 2005. Deletion of Abcal increases abeta deposition in the PDAPP transgenic mouse model of Alzheimer disease. J Biol Chem 280:43236-43242.
26. Wollmer MA, Streffer JR, Lutjohann D, Tsolaki M, Iakovidou V, Hegi T, Pasch T, Jung HH, Bergmann K, Nitsch RM, Hock C, Papassotiropoulos A. 2003. ABCA1 modulates CSF cholesterol levels and influences the age at onset of Alzheimer's disease. Neurobiol Aging 24:421-426.
27. Wolozin B. 2001. A fluid connection: Cholesterol and abeta. Proc Natl Acad Sci USA 98:5371-5373.
28. Wolozin B. 2003. Cyp46 (24S-cholesterol hydroxylase): A genetic risk factor for Alzheimer disease. Arch Neurol 60:16-18.
29. Wolozin B. 2004. Cholesterol and the biology of Alzheimer's disease. Neuron 41:7-10.
30. Wolozin B, Kellman W, Ruosseau P, Celesia GG, Siegel G. 2000. Decreased prevalence of Alzheimer disease associated with 3-hydroxy-3-methyglutaryl coenzyme A reductase inhibitors. Arch Neurol 57:1439-1443.